Vital Chemtech's Q4 FY26 EBITDA rose 39.7% to ₹4.0 Cr.

Vital Chemtech LimitedVITAL · Filed with the exchange

Full-year PAT declined to ₹1.0 Cr, impacted by investments in subsidiaries Vital Synthesis (now operational) and Vital Alkoxides (63% revenue growth). Focus is on long-term specialty chemical expansion.

Read the original filing(PDF)

No comments yet. Be the first.

More from Vital Chemtech Limited

All announcements

Updates07-09-2026
General Updates
Others07-09-2026
Copy of Newspaper Publication
Others05-09-2026
Shareholders meeting
Board Meeting31-08-2026
Outcome of Board Meeting
Others17-08-2026
Copy of Newspaper Publication
Important14-08-2026
Updates

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.